Literature DB >> 8405019

Metformin-associated lactic acidosis in Sweden 1977-1991.

B E Wiholm1, M Myrhed.   

Abstract

Since the withdrawal of phenformin in 1978, the use of metformin has increased from 13,500 to 22,000 patient years/year. During the period 1977-91 a total of 18 cases of metformin-associated acidosis was reported, of which 16 had lactic acidosis. The incidence of reported acidosis and lactic acidosis decreased from 1.50 cases per 10,000 patient years in 1977-81 to 0.24 cases per 10,000 patient years 1987-91, probably due to lower doses doses and reduced usage in the very old. All the reports described patients with several other concomitant diseases, mainly cardiovascular and renal, when the acidosis was diagnosed. It is important continuously to re-evaluate metformin therapy and to stop treatment at the onset of impaired renal or cardiovascular function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405019     DOI: 10.1007/bf02440866

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

Review 1.  Antidiabetic drugs after the University Group Diabetes Program (UGDP).

Authors:  J H Karam; S B Matin; P H Forsham
Journal:  Annu Rev Pharmacol       Date:  1975       Impact factor: 13.820

Review 2.  Biguanides and lactate metabolism: a review.

Authors:  L S Hermann
Journal:  Dan Med Bull       Date:  1973-06

3.  Effect of biguanides on intestinal absorption of glucose.

Authors:  A Czyzyk; J Tawecki; J Sadowski; I Ponikowska; Z Szczepanik
Journal:  Diabetes       Date:  1968-08       Impact factor: 9.461

4.  Hydroxylation of debrisoquine in patients with lacticacidosis after phenformin.

Authors:  B E Wiholm; G Alvan; L Bertilsson; J Sawe; F Sjöqvist
Journal:  Lancet       Date:  1981-05-16       Impact factor: 79.321

5.  Genetic impairment of phenformin metabolism.

Authors:  R R Shah; N S Oates; J R Idle; R L Smith
Journal:  Lancet       Date:  1980-05-24       Impact factor: 79.321

6.  Metformin and glibenclamide: comparative risks.

Authors:  I W Campbell
Journal:  Br Med J (Clin Res Ed)       Date:  1984-08-04

7.  Epidemiology of adverse drug reactions to phenformin and metformin.

Authors:  U Bergman; G Boman; B E Wiholm
Journal:  Br Med J       Date:  1978-08-12

Review 8.  Role of metformin in treatment of diabetes mellitus.

Authors:  R Vigneri; I D Goldfine
Journal:  Diabetes Care       Date:  1987 Jan-Feb       Impact factor: 19.112

Review 9.  Lactic acidosis in biguanide-treated diabetics: a review of 330 cases.

Authors:  D Luft; R M Schmülling; M Eggstein
Journal:  Diabetologia       Date:  1978-02       Impact factor: 10.122

10.  The mechanism of the acute hypoglycemic action of phenformin (DBI).

Authors:  G L Searle; R Gulli
Journal:  Metabolism       Date:  1980-07       Impact factor: 8.694

  10 in total
  26 in total

Review 1.  Case-population studies in pharmacoepidemiology.

Authors:  Dolors Capellà; Consuelo Pedrós; Xavier Vidal; Joan-Ramon Laporte
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  [Metformin-associated lactic acidosis with acute renal failure in type 2 diabetes mellitus].

Authors:  Heinrich Lothholz
Journal:  Med Klin (Munich)       Date:  2002-07-15

Review 3.  Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

Authors:  Silvio E Inzucchi; Kasia J Lipska; Helen Mayo; Clifford J Bailey; Darren K McGuire
Journal:  JAMA       Date:  2014 Dec 24-31       Impact factor: 56.272

4.  Toxicokinetics of metformin-associated lactic acidosis with continuous renal replacement therapy.

Authors:  Muhammad Mujtaba; Abdallah Sassine Geara; Machaiah Madhrira; Rajesh Agarwala; Herman Anderson; Jen-Tse Cheng; Sumit Mohan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-08-29       Impact factor: 2.441

Review 5.  A risk-benefit assessment of metformin in type 2 diabetes mellitus.

Authors:  H C Howlett; C J Bailey
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

Review 6.  Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

Authors:  Shelley R Salpeter; Elizabeth Greyber; Gary A Pasternak; Edwin E Salpeter
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

7.  Metformin in peritoneal dialysis: a pilot experience.

Authors:  Abdulla Khalaf Al-Hwiesh; Ibrahiem Saeed Abdul-Rahman; Mohammad Ahmad Nasr El-Deen; Emmanuel Larbi; Jose C Divino-Filho; Fahd Abdul-Aziz Al-Mohanna; Krishan L Gupta
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

8.  The Association between Metformin Therapy and Lactic Acidosis.

Authors:  Isabelle H S Kuan; Ruth L Savage; Stephen B Duffull; Robert J Walker; Daniel F B Wright
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

Review 9.  Management of antidiabetic medications in overdose.

Authors:  H A Spiller
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

10.  Metformin protects against infection-induced myocardial dysfunction.

Authors:  Theodora Tzanavari; Aimilia Varela; Stamatis Theocharis; Elpinickie Ninou; Alkistis Kapelouzou; Dennis V Cokkinos; Maria I Kontaridis; Katia P Karalis
Journal:  Metabolism       Date:  2016-07-09       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.